Composition For Treating Or Preventing Metabolic Disease, Containing, As Active Ingredient, Extracellular Vesicles Derived From Akkermansia Muciniphila Bacteria

Patent No. EP3165227 (titled "Composition For Treating Or Preventing Metabolic Disease, Containing, As Active Ingredient, Extracellular Vesicles Derived From Akkermansia Muciniphila Bacteria") was filed by MD Healthcare on May 19, 2015. The application was issued on Oct 27, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ICOSA EUROPEDec 13, 2019WILLNEGGER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3165227

MD HEALTHCARE
Application Number
EP15796520A
Filing Date
May 19, 2015
Status
Patent Maintained As Amended
Sep 24, 2021
Publication Date
Oct 27, 2021